Kennedy John Jed's Form 4 filing
CONMED Corp (CNMD) · filed Aug 30, 2021
- Accession no.
- 0001127602-21-024541
- Filed
- Aug 30, 2021
- Trade date
- Aug 27, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $732.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy John JedCIK 0001287981 | Officer (Group Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | Common Stock | MOption exerciseAcquired | +4,940 | $39.87 | +$196,957.8 | 12,315 | Direct | |
| Aug 27, 2021 | Common Stock | SSaleDisposed | −4,940 | $134.78F1 | −$665,813.2 | 7,375 | Direct | |
| Aug 27, 2021 | Common Stock | MOption exerciseAcquired | +498 | $41.93 | +$20,881.14 | 7,873 | Direct | |
| Aug 27, 2021 | Common Stock | SSaleDisposed | −498 | $134.75 | −$67,105.5 | 7,375 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | Common Stock | MOption exerciseDisposed | −4,940 | $0.00 | $0 | 0 | Direct | |
| Aug 27, 2021 | Common Stock | MOption exerciseDisposed | −498 | $0.00 | $0 | 9,502 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $135.05. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.